SCHEMBL1089744

SCHEMBL1089744

O=S(=O)(c1ccccc1)N1CCC(N2CCCCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ CXCR4 P61073 1/20 0.53
▸ HRH4 Q9H3N8 3/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ EPHX2 P34913 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ IDH1 O75874 2/20 0.42
▸ HPGD P15428 1/20 0.41
▸ MAPK8 P45983 3/20 0.41
▸ MAPK9 P45984 2/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ IKBKB O14920 1/20 0.40
▸ MBTD1 Q05BQ5 1/20 0.40
▸ L3MBTL3 Q96JM7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090389 0.98 KDM4E (0.54) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1091155 0.95 CXCR4 (0.56) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1090079 0.91 ALDH1A1 (0.55) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1089898 0.91 CXCR4 (0.52) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1090153 0.91 ALDH1A1 (0.55) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1091119 0.91 KDM4E (0.48) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1089353 0.90 CXCR4 (0.52) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1089174 0.90 EPHX2 (0.48) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1090475 0.89 ALDH1A1 (0.55) GAAKDM4ECXCR4HRH4ALDH1A1
SCHEMBL1089014 0.89 ALDH1A1 (0.55) GAAKDM4ECXCR4HRH4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 GAA 4229/4885KDM4E 2001/4885CXCR4 1/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 GAA 4229/4885KDM4E 2001/4885CXCR4 1/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 GAA 4229/4885KDM4E 2001/4885CXCR4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback